Clinical trials
Pancreatic Intraductal Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 3 |
| Completed | 3 |
| Recruiting | 3 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| National Cancer Institute (NCI) | 2 |
| Adenocyte, LLC | 1 |
| Duke University | 1 |
| Eli Lilly and Company | 1 |
| Indiana University | 1 |
| OHSU Knight Cancer Institute | 1 |
| Ohio State University Comprehensive Cancer Center | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 1 |
| University of California, San Francisco | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Intraductal Neoplasms | 12 |
| Pancreatic Neoplasms | 6 |
| Pancreatic Cyst | 3 |
| Cholangiocarcinoma | 2 |
| Breast Neoplasms | 1 |
| Carcinoma, Acinar Cell | 1 |
| Colorectal Neoplasms | 1 |
| Cystadenocarcinoma, Mucinous | 1 |
| Cystadenoma, Mucinous | 1 |
| Cystadenoma, Serous | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.